IBM

International Business Machines Corporation

65
Fundamentals71/ 100
Valuation57/ 100
Upside potential62/ 100
Risk potential15/ 100

IBM has lower modeled downside risk, despite its lower overall score.

RDDT

Reddit, Inc.

70
Fundamentals88/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential41/ 100

RDDT has the edge over IBM overall, supported by stronger fundamentals and stronger modeled upside.

IBM Fundamentals

MetricStatus
Stable
Strong
Strong
Under pressure

IBM's profitability and cash flow are currently strong, and its revenue is stable, but its balance sheet is under pressure.

RDDT Fundamentals

MetricStatus
Healthy
Strong
Strong
Strong

RDDT's revenue, profitability, cash flow and balance sheet are all currently healthy.

IBM PE Valuation

CHEAPFAIREXPENSIVE28x56x85x113x
CHEAPFAIREXPENSIVE28x56x85x113x
LevelPEPriceVs current
Cheap17x$194-21%
Forward19x$245—
Current21x$245—
Fair23x$274+12%
Expensive46x$538+120%

Historical ranges are pointers, not guarantees.

IBM's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.

RDDT PE Valuation

CHEAPFAIREXPENSIVE16x33x49x65x
CHEAPFAIREXPENSIVE16x33x49x65x
LevelPEPriceVs current
Forward16x$99.55—
Current20x$99.55—
Cheap35x$171+72%
Fair46x$228+129%
Expensive53x$262+163%

Historical ranges are pointers, not guarantees.

RDDT has the edge over IBM in the historical PE scenario, which offers more potential upside but is not a forecast.

IBM Forward outlook

MetricOutlook
Improving
Growth
Stable
Improving
Moderate
Moderate

Analysts expect IBM's earnings to grow and its profitability to improve, with its revenue holding steady.

RDDT Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Low

RDDT has the edge over IBM on the outlook, with more favorable revenue expectations.

IBM Risk to reward

ScenarioChangePrice
Upside+26%$307.43
Downside-15%$206.85

Calculated from the latest close: $244.67 on Nov 12.

IBM trails RDDT on modeled risk to reward, with less potential upside relative to its potential downside.

RDDT Risk to reward

ScenarioChangePrice
Upside+77%$175.99
Downside-41%$58.49

Calculated from the latest close: $99.55 on Nov 12.

RDDT has a better modeled risk to reward balance than IBM, with more potential upside relative to its potential downside.

IBM Earnings Per Share

Q4 2023: $8.14Q1 2024: $8.85Q2 2024: $9.09Q3 2024: $6.89Q4 2024: $6.43Q1 2025: $5.83Q2 2025: $6.18Q3 2025: $8.38Q4 2025: $11.17Q1 2026: $11.33Q2 2026: $11.29Q3 2026: $11.75Forward: $13.06
Q4 2023: $8.14Q1 2024: $8.85Q2 2024: $9.09Q3 2024: $6.89Q4 2024: $6.43Q1 2025: $5.83Q2 2025: $6.18Q3 2025: $8.38Q4 2025: $11.17Q1 2026: $11.33Q2 2026: $11.29Q3 2026: $11.75Forward: $13.06
QuarterTTM EPSYoY
Forward$13.06+11%
Q3 2026$11.75+40%
Q2 2026$11.29+83%
Q1 2026$11.33+94%
Q4 2025$11.17+74%
Q3 2025$8.38+22%
Q2 2025$6.18-32%
Q1 2025$5.83-34%
Q4 2024$6.43-21%

IBM has the stronger earnings trend. Trailing diluted EPS is up 40% for IBM versus RDDT down 39%.

RDDT Earnings Per Share

Q4 2023: $-0.56Q1 2024: $-8.38Q2 2024: $-8.19Q3 2024: $-7.98Q4 2025: $2.62Q1 2026: $3.50Q2 2026: $4.30Q3 2026: $4.90Forward: $6.32
Q4 2023: $-0.56Q1 2024: $-8.38Q2 2024: $-8.19Q3 2024: $-7.98Q4 2025: $2.62Q1 2026: $3.50Q2 2026: $4.30Q3 2026: $4.90Forward: $6.32
QuarterTTM EPSYoY
Forward$6.32+29%
Q3 2024-$7.98-$7.17
Q2 2024-$8.19-$7.15
Q1 2024-$8.38-$7.25
Q4 2023-$0.56+$0.41
Q3 2023-$0.81-$0.02
Q2 2023-$1.04-$0.48
Q1 2023-$1.13-$0.48
Q4 2022-$0.97-$0.19

RDDT has returned to profit: it earned $4.90 per share over the past year, after losing money the year before.

IBM Quarterly Revenue

Q4 2023: $17.4BQ1 2024: $14.5BQ2 2024: $15.8BQ3 2024: $15BQ4 2024: $17.6BQ1 2025: $14.5BQ2 2025: $17BQ3 2025: $16.3BQ4 2025: $19.7BQ1 2026: $15.9BQ2 2026: $17.2BQ3 2026: $17.1B
Q4 2023: $17.4BQ1 2024: $14.5BQ2 2024: $15.8BQ3 2024: $15BQ4 2024: $17.6BQ1 2025: $14.5BQ2 2025: $17BQ3 2025: $16.3BQ4 2025: $19.7BQ1 2026: $15.9BQ2 2026: $17.2BQ3 2026: $17.1B
QuarterRevenueYoY
Q3 2026$17.1B+4.7%
Q2 2026$17.2B+1.1%
Q1 2026$15.9B+9.5%
Q4 2025$19.7B+12%
Q3 2025$16.3B+9.1%
Q2 2025$17B+7.7%
Q1 2025$14.5B+0.5%
Q4 2024$17.6B+1%

IBM's revenue has grown year over year for 13 quarters in a row: $17.1B last quarter, up 4.7% from the same quarter a year ago.

RDDT Quarterly Revenue

Q4 2023: $250MQ1 2024: $243MQ2 2024: $281MQ3 2024: $348MQ4 2024: $428MQ1 2025: $392MQ2 2025: $500MQ3 2025: $585MQ4 2025: $726MQ1 2026: $663MQ2 2026: $805MQ3 2026: $895M
Q4 2023: $250MQ1 2024: $243MQ2 2024: $281MQ3 2024: $348MQ4 2024: $428MQ1 2025: $392MQ2 2025: $500MQ3 2025: $585MQ4 2025: $726MQ1 2026: $663MQ2 2026: $805MQ3 2026: $895M
QuarterRevenueYoY
Q3 2026$895M+53%
Q2 2026$804.9M+61%
Q1 2026$663.4M+69%
Q4 2025$725.6M+70%
Q3 2025$584.9M+68%
Q2 2025$499.6M+78%
Q1 2025$392.4M+61%
Q4 2024$427.7M+71%

RDDT has the edge over IBM on sales, with stronger typical year-over-year growth.

IBM Free Cash Flow

Q4 2023: $4.2BQ1 2024: $3.9BQ2 2024: $1.8BQ3 2024: $2.6BQ4 2024: $4BQ1 2025: $4.1BQ2 2025: $1.5BQ3 2025: $2.8BQ4 2025: $3.7BQ1 2026: $4.9BQ2 2026: $2.4BQ3 2026: $3.7B
Q4 2023: $4.2BQ1 2024: $3.9BQ2 2024: $1.8BQ3 2024: $2.6BQ4 2024: $4BQ1 2025: $4.1BQ2 2025: $1.5BQ3 2025: $2.8BQ4 2025: $3.7BQ1 2026: $4.9BQ2 2026: $2.4BQ3 2026: $3.7B
QuarterFree cash flowYoY
Q3 2026$3.7B+31%
Q2 2026$2.4B+59%
Q1 2026$4.9B+20%
Q4 2025$3.7B-9.2%
Q3 2025$2.8B+8.9%
Q2 2025$1.5B-19%
Q1 2025$4.1B+5%
Q4 2024$4B-3.3%

IBM's free cash flow has been positive every quarter for seven years: $14.7B over the past year, up 18% from the year before.

RDDT Free Cash Flow

Q4 2023: −$22MQ1 2024: $29MQ2 2024: $27MQ3 2024: $70MQ4 2024: $89MQ1 2025: $127MQ2 2025: $111MQ3 2025: $183MQ4 2025: $264MQ1 2026: $311MQ2 2026: $261MQ3 2026: $363M
Q4 2023: −$22MQ1 2024: $29MQ2 2024: $27MQ3 2024: $70MQ4 2024: $89MQ1 2025: $127MQ2 2025: $111MQ3 2025: $183MQ4 2025: $264MQ1 2026: $311MQ2 2026: $261MQ3 2026: $363M
QuarterFree cash flowYoY
Q3 2026$362.6M+98%
Q2 2026$260.7M+135%
Q1 2026$311.2M+146%
Q4 2025$263.6M+196%
Q3 2025$183.1M+161%
Q2 2025$110.8M+308%
Q1 2025$126.6M+333%
Q4 2024$89.2M+$111.2M

RDDT has the edge over IBM on cash flow, with more consistent year-over-year improvement.

IBM Total Shares

Q4 2023: 922MQ1 2024: 933MQ2 2024: 934MQ3 2024: 924MQ4 2024: 937MQ1 2025: 945MQ2 2025: 948MQ3 2025: 949MQ4 2025: 949MQ1 2026: 952MQ2 2026: 953MQ3 2026: 954M
Q4 2023: 922MQ1 2024: 933MQ2 2024: 934MQ3 2024: 924MQ4 2024: 937MQ1 2025: 945MQ2 2025: 948MQ3 2025: 949MQ4 2025: 949MQ1 2026: 952MQ2 2026: 953MQ3 2026: 954M
PeriodChange %Net change
Quarterly0%+260K shares
1 year+0.5%+4.6M shares
3 years+3.2%+29.9M shares
5 years+5.3%+47.6M shares
Available history+2.1%+19.6M shares

IBM has 954M diluted shares, about the same as a year ago.

RDDT Total Shares

Q4 2023: 163MQ1 2024: 70MQ2 2024: 164MQ3 2024: 192MQ1 2025: 201MQ2 2025: 200MQ3 2025: 203MQ4 2025: 202MQ1 2026: 203MQ2 2026: 202MQ3 2026: 202M
Q4 2023: 163MQ1 2024: 70MQ2 2024: 164MQ3 2024: 192MQ1 2025: 201MQ2 2025: 200MQ3 2025: 203MQ4 2025: 202MQ1 2026: 203MQ2 2026: 202MQ3 2026: 202M
PeriodChange %Net change
Quarterly-0.1%-169K shares
1 year-0.4%-868K shares
3 years+24%+38.5M shares
5 years+24%+38.5M shares

RDDT has the edge over IBM on shareholder dilution, with a more favorable share count trend.

IBM Net Leverage

Q4 2023: 3.8xQ1 2024: 3.8xQ2 2024: 3.6xQ3 2024: 4.3xQ4 2024: 4.4xQ1 2025: 5.6xQ2 2025: 5.5xQ3 2025: 4.2xQ4 2025: 3.5xQ1 2026: 4.0xQ2 2026: 3.9xQ3 2026: 3.9x
Q4 2023: 3.8xQ1 2024: 3.8xQ2 2024: 3.6xQ3 2024: 4.3xQ4 2024: 4.4xQ1 2025: 5.6xQ2 2025: 5.5xQ3 2025: 4.2xQ4 2025: 3.5xQ1 2026: 4.0xQ2 2026: 3.9xQ3 2026: 3.9x
QuarterNet LeverageStatus
Q3 20263.9xElevated
Q2 20263.9xElevated
Q1 20264.0xHigh
Q4 20253.5xElevated
Q3 20254.2xHigh
Q2 20255.5xHigh
Q1 20255.6xHigh
Q4 20244.4xHigh

IBM's net debt is about 3.9 years of its operating earnings (EBITDA), down from 4.2 years a year ago.

RDDT Net Leverage

Q1 2025: -13.1xQ2 2025: -5.0xQ3 2025: -3.3xQ4 2025: -2.1xQ1 2026: -2.2xQ2 2026: -1.9xQ3 2026: -1.5x
Q1 2025: -13.1xQ2 2025: -5.0xQ3 2025: -3.3xQ4 2025: -2.1xQ1 2026: -2.2xQ2 2026: -1.9xQ3 2026: -1.5x
QuarterNet LeverageStatus
Q3 2026-1.5xNet Cash
Q2 2026-1.9xNet Cash
Q1 2026-2.2xNet Cash
Q4 2025-2.1xNet Cash
Q3 2025-3.3xNet Cash
Q2 2025-5.0xNet Cash
Q1 2025-13.1xNet Cash

RDDT has the edge over IBM on leverage, with a lower net debt burden relative to earnings.

IBM Weekly Momentum

MetricValueStatus
RSI50.1Neutral
Stochastic74.8Neutral

IBM's weekly RSI is 50 (neutral) and its Stochastic is 75 (neutral).

RDDT Weekly Momentum

MetricValueStatus
RSI34.8Neutral
Stochastic6.5Oversold

RDDT's weekly RSI is 35 (neutral) and its Stochastic is 6 (oversold).

IBM PE vs Technology Sector

MetricIBMSector medianRelative
PE21x28x25% below
PE %31354 pts below

IBM has the edge over RDDT on valuation relative to its sector.

RDDT PE vs Communication Services Sector

MetricRDDTSector medianRelative
PE20x16x23% above
PE %52318 pts below

RDDT is trading at 20x earnings, a 23% premium to the Communication Services sector's median of 16x, though its earnings don't support one.

IBM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$238.62.6% above
20 week MA$239.32.2% above
50 week MA$256.64.6% below
100 week MA$258.55.3% below
200 week MA$212.315% above

IBM has stronger trend alignment. IBM is above 3 of 5 weekly averages versus RDDT above 0 of 4.

RDDT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$130.624% below
20 week MA$151.734% below
50 week MA$165.040% below
100 week MA$167.140% below

RDDT is in a downtrend: it's below all four of its weekly moving averages, and 40% below its 100-week average.

IBM Yearly ROI

YearStart priceEnd priceROI
2020$129.3$119.2-7.8%
2021$119.2$130.6+9.6%
2022$130.6$141.7+8.4%
2023$141.7$163.6+15%
2024$163.6$222.8+36%
2025$222.8$305.1+37%
2026 YTD$305.1$244.7-20%

IBM has the edge over RDDT on returns for 2026, with the stronger performance.

RDDT Yearly ROI

YearStart priceEnd priceROI
2024$46.0$173.5+277%
2025$173.5$225.8+30%
2026 YTD$225.8$99.6-56%

RDDT has finished every year since 2024 higher, and it's down 56% so far in 2026.

Give your agent the market.

Get API key